Hu CY - Search Results

1

Gankyrin is a novel biomarker for disease progression and prognosis of patients with renal cell carcinoma.

Wang C, Li Y, Chu CM, Zhang XM, Ma J, Huang H, Wang YN, Hong TY, Zhang J, Pan XW, Zheng JC, Jiang N, Hu CY, Ma X, Sun YH, Cui XG. Wang C, et al. Among authors: hu cy. EBioMedicine. 2019 Jan;39:255-264. doi: 10.1016/j.ebiom.2018.12.011. Epub 2018 Dec 14. EBioMedicine. 2019. PMID: 30558998 Free PMC article.

2

Expression of hepatocyte growth factor activator inhibitor-1 (HAI-1) gene in prostate cancer: clinical and biological significance.

Hu C, Jiang N, Wang G, Zheng J, Yang W, Yang J. Hu C, et al. J BUON. 2014 Jan-Mar;19(1):215-20. J BUON. 2014. PMID: 24659667 Free article.

3

Long non-coding RNA XIST promotes cell growth and metastasis through regulating miR-139-5p mediated Wnt/β-catenin signaling pathway in bladder cancer.

Hu Y, Deng C, Zhang H, Zhang J, Peng B, Hu C. Hu Y, et al. Oncotarget. 2017 Oct 10;8(55):94554-94568. doi: 10.18632/oncotarget.21791. eCollection 2017 Nov 7. Oncotarget. 2017. Retraction in: Oncotarget. 2022 Nov 17;13:1258. doi: 10.18632/oncotarget.28314 PMID: 29212249 Free PMC article. Retracted.

4

Comparison of the Efficacy of Ultra-Mini PCNL, Flexible Ureteroscopy, and Shock Wave Lithotripsy on the Treatment of 1-2 cm Lower Pole Renal Calculi.

Zhang H, Hong TY, Li G, Jiang N, Hu C, Cui X, Chu C, Zhao JL. Zhang H, et al. Urol Int. 2019;102(2):153-159. doi: 10.1159/000493508. Epub 2018 Oct 23. Urol Int. 2019. PMID: 30352443 Clinical Trial.

5

LRP11 activates β-catenin to induce PD-L1 expression in prostate cancer.

Gan S, Ye J, Li J, Hu C, Wang J, Xu D, Pan X, Chu C, Chu J, Zhang J, Zheng J, Zhang X, Xu J, Zhang H, Qu F, Cui X. Gan S, et al. J Drug Target. 2020 Jun;28(5):508-515. doi: 10.1080/1061186X.2019.1687710. Epub 2019 Dec 27. J Drug Target. 2020. PMID: 31865764

6

Long non-coding RNA NORAD promotes the prostate cancer cell extracellular vesicle release via microRNA-541-3p-regulated PKM2 to induce bone metastasis of prostate cancer.

Hu CY, Chen J, Qin XH, You P, Ma J, Zhang J, Zhang H, Xu JD. Hu CY, et al. J Exp Clin Cancer Res. 2021 Mar 16;40(1):98. doi: 10.1186/s13046-021-01891-0. J Exp Clin Cancer Res. 2021. PMID: 33722248 Free PMC article.

7

Clinical Outcomes and Prognosis Analysis of Younger Bladder Cancer Patients.

Abudurexiti M, Ma J, Li Y, Hu C, Cai Z, Wang Z, Jiang N. Abudurexiti M, et al. Curr Oncol. 2022 Jan 28;29(2):578-588. doi: 10.3390/curroncol29020052. Curr Oncol. 2022. PMID: 35200552 Free PMC article.

8

The efficacy and safety of dutasteride and finasteride in patients with benign prostatic hyperplasia: a systematic review and meta-analysis.

Li Y, Ma J, Qin XH, Hu CY. Li Y, et al. Among authors: hu cy. Transl Androl Urol. 2022 Mar;11(3):313-324. doi: 10.21037/tau-22-58. Transl Androl Urol. 2022. PMID: 35402192 Free PMC article.

9

Retraction: Long non-coding RNA XIST promotes cell growth and metastasis through regulating miR-139-5p mediated Wnt/β-catenin signaling pathway in bladder cancer.

Hu Y, Deng C, Zhang H, Zhang J, Peng B, Hu C. Hu Y, et al. Oncotarget. 2022 Nov 17;13:1258. doi: 10.18632/oncotarget.28314. Oncotarget. 2022. PMID: 36395363 Free article. No abstract available.

10

Albumin and Fibrinogen Combined Prognostic Grade Predicts Prognosis of Patients with Prostate Cancer.

Wang Y, Chen W, Hu C, Wen X, Pan J, Xu F, Zhu Y, Shao X, Shangguan X, Fan L, Sha J, Wang Z, Cai Y, Liu Q, Dong B, Xue W. Wang Y, et al. J Cancer. 2017 Oct 23;8(19):3992-4001. doi: 10.7150/jca.21061. eCollection 2017. J Cancer. 2017. PMID: 29187874 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

856 results

Search Page

Filters